HEALTH ECONOMICS

Clinical benefits (efficacy, safety and quality) are important parameters when considering health policy. However, given the notion of scarcity, the allocation of scarce health resources has become a science on its own. Health economics and pharmacoeconomics are important tools to assist you in communicating the economic value related to your product’s clinical value.

VI Research provides the following health economics services:

  • Development of cost-effectiveness models
  • Adaptation and localisation of global cost-effectiveness models
  • Sourcing of data from literature, reference price lists, key opinion leader consultation, Delphi panels, claims line data analysis
  • Development of budget impact models
  • Adaptation and localisation of global budget impact models
  • Sourcing of data from literature, reference price lists, key opinion leader consultation, Delphi panels, claims line data analysis
  • Costing of interventions
  • Cost of illness studies
  • Price elasticity of demand studies
  • Alternative reimbursement and risk sharing studies